Literature DB >> 29055663

Damage control: Concept and implementation.

B Malgras1, B Prunet2, X Lesaffre3, G Boddaert4, S Travers3, P-J Cungi2, E Hornez5, O Barbier6, H Lefort3, S Beaume2, M Bignand3, J Cotte2, P Esnault2, J-L Daban7, J Bordes2, E Meaudre8, J-P Tourtier9, S Gaujoux10, S Bonnet11.   

Abstract

The concept of damage control (DC) is based on a sequential therapeutic strategy that favors physiological restoration over anatomical repair in patients presenting acutely with hemorrhagic trauma. Initially described as damage control surgery (DCS) for war-wounded patients with abdominal penetrating hemorrhagic trauma, this concept is articulated in three steps: surgical control of lesions (hemostasis, sealing of intestinal spillage), physiological restoration, then surgery for definitive repair. This concept was quickly adapted for intensive care management under the name damage control resuscitation (DCR), which refers to the modalities of hospital resuscitation carried out in patients suffering from traumatic hemorrhagic shock within the context of DCS. It is based mainly on specific hemodynamic resuscitation targets associated with early and aggressive hemostasis aimed at prevention or correction of the lethal triad of hypothermia, acidosis and coagulation disorders. Concomitant integration of resuscitation and surgery from the moment of admission has led to the concept of an integrated DCR-DCS approach, which enables initiation of hemostatic resuscitation upon arrival of the injured person, improving the patient's physiological status during surgery without delaying surgery. This concept of DC is constantly evolving; it stresses management of the injured person as early as possible, in order to initiate hemorrhage control and hemostatic resuscitation as soon as possible, evolving into a concept of remote DCR (RDCR), and also extended to diagnostic and therapeutic radiological management under the name of radiological DC (DCRad). DCS is applied only to the most seriously traumatized patients, or in situations of massive influx of injured persons, as its universal application could lead to a significant and unnecessary excess-morbidity to injured patients who could and should undergo definitive treatment from the outset. DCS, when correctly applied, significantly improves the survival rate of war-wounded.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Coagulopathy; Damage control; Damage control resuscitation; Damage control surgery; Lethal triad; Remote damage control resuscitation; Traumatic hemorrhagic shock

Mesh:

Year:  2017        PMID: 29055663     DOI: 10.1016/j.jviscsurg.2017.08.012

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  5 in total

Review 1.  Management of peripartum intra-abdominal hypertension and abdominal compartment syndrome.

Authors:  M James Lozada; Varun Goyal; Danielle Levin; Rachel L Walden; Sarah S Osmundson; Luis D Pacheco; Manu L N G Malbrain
Journal:  Acta Obstet Gynecol Scand       Date:  2019-06-18       Impact factor: 3.636

2.  Adding the Capacity for an Intensive Care Unit Dedicated to COVID 19, Preserving the Operational Capability of a French Golden Hour Offset Surgical Team in Sahel.

Authors:  Henri de Lesquen; Marie Bergez; Antoine Vuong; Alexandre Boufime-Jonqheere; Nicolas de l'Escalopier
Journal:  Mil Med       Date:  2020-11-10       Impact factor: 1.437

Review 3.  Military training-related abdominal injuries and diseases: Common types, prevention and treatment.

Authors:  Chuan Pang; Zhi-Da Chen; Bo Wei; Wen-Tong Xu; Hong-Qing Xi
Journal:  Chin J Traumatol       Date:  2022-03-10

4.  The Tumbling Bullet: Subacute Intestinal Obstruction due to a Retained Bullet.

Authors:  Anupam K Gupta; Blake Edwards; Jorge A Vega
Journal:  Cureus       Date:  2020-08-18

Review 5.  Establishment of a combat damage control surgery training platform for explosive combined thoraco-abdominal injuries.

Authors:  Wen-Qiong Du; Ren-Qing Jiang; Zhao-Wen Zong; Lin Zhang; Zhao Ye; Xin Zhong; Yi-Jun Jia
Journal:  Chin J Traumatol       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.